Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hospitals | 74 | 2021 | 3906 | 9.810 |
Why?
|
Quality of Health Care | 70 | 2020 | 4340 | 7.860 |
Why?
|
Medicare | 98 | 2024 | 6881 | 7.610 |
Why?
|
Hospital Administration | 23 | 2021 | 353 | 6.280 |
Why?
|
Patient Readmission | 47 | 2021 | 3308 | 5.980 |
Why?
|
Reimbursement, Incentive | 22 | 2020 | 548 | 5.470 |
Why?
|
Health Expenditures | 33 | 2023 | 2391 | 5.190 |
Why?
|
Quality Indicators, Health Care | 34 | 2021 | 1813 | 4.470 |
Why?
|
Electronic Health Records | 37 | 2021 | 4877 | 3.860 |
Why?
|
Hospital Mortality | 37 | 2021 | 5371 | 3.800 |
Why?
|
Diffusion of Innovation | 22 | 2021 | 730 | 3.610 |
Why?
|
Developed Countries | 11 | 2021 | 451 | 3.280 |
Why?
|
United States | 224 | 2024 | 73121 | 3.240 |
Why?
|
Fee-for-Service Plans | 23 | 2021 | 714 | 3.190 |
Why?
|
Quality Assurance, Health Care | 20 | 2018 | 2179 | 3.160 |
Why?
|
Health Care Costs | 23 | 2021 | 3265 | 2.790 |
Why?
|
Economics, Hospital | 12 | 2017 | 210 | 2.730 |
Why?
|
Patient Satisfaction | 17 | 2017 | 3484 | 2.680 |
Why?
|
Delivery of Health Care | 26 | 2024 | 5367 | 2.430 |
Why?
|
Medical Informatics | 10 | 2018 | 737 | 2.310 |
Why?
|
Hospitals, Veterans | 8 | 2016 | 395 | 2.250 |
Why?
|
Healthcare Disparities | 20 | 2021 | 3412 | 2.220 |
Why?
|
Efficiency, Organizational | 11 | 2015 | 699 | 2.150 |
Why?
|
Hospitals, Rural | 6 | 2020 | 176 | 2.130 |
Why?
|
Pneumonia | 23 | 2020 | 2162 | 2.100 |
Why?
|
Cost Savings | 13 | 2021 | 916 | 1.990 |
Why?
|
Hospitals, Teaching | 11 | 2023 | 1158 | 1.870 |
Why?
|
Surgical Procedures, Operative | 9 | 2021 | 1937 | 1.830 |
Why?
|
Medical Records Systems, Computerized | 16 | 2015 | 1193 | 1.780 |
Why?
|
Hospitalization | 29 | 2021 | 10845 | 1.720 |
Why?
|
Myocardial Infarction | 29 | 2020 | 11515 | 1.690 |
Why?
|
Health Care Reform | 9 | 2019 | 1256 | 1.600 |
Why?
|
Health Policy | 16 | 2022 | 2699 | 1.580 |
Why?
|
Humans | 349 | 2024 | 768451 | 1.560 |
Why?
|
Hospital Costs | 12 | 2019 | 959 | 1.550 |
Why?
|
Health Facility Merger | 3 | 2017 | 47 | 1.540 |
Why?
|
Hospital Bed Capacity | 13 | 2017 | 206 | 1.540 |
Why?
|
Heart Failure | 32 | 2021 | 11857 | 1.530 |
Why?
|
Health Services Accessibility | 21 | 2020 | 5510 | 1.510 |
Why?
|
American Recovery and Reinvestment Act | 7 | 2012 | 72 | 1.500 |
Why?
|
Patient Protection and Affordable Care Act | 16 | 2022 | 1189 | 1.470 |
Why?
|
Quality Improvement | 15 | 2021 | 3858 | 1.390 |
Why?
|
Hospitals, Voluntary | 3 | 2014 | 39 | 1.390 |
Why?
|
Patient Acceptance of Health Care | 7 | 2024 | 3237 | 1.290 |
Why?
|
Foreign Medical Graduates | 2 | 2021 | 77 | 1.270 |
Why?
|
Hospitalists | 5 | 2018 | 298 | 1.260 |
Why?
|
Climate Change | 4 | 2020 | 510 | 1.240 |
Why?
|
Public-Private Sector Partnerships | 2 | 2019 | 123 | 1.210 |
Why?
|
Insurance Coverage | 11 | 2022 | 1946 | 1.190 |
Why?
|
Hospitals, Community | 6 | 2023 | 365 | 1.180 |
Why?
|
Medical Record Linkage | 4 | 2011 | 286 | 1.170 |
Why?
|
Insurance, Health, Reimbursement | 4 | 2019 | 389 | 1.160 |
Why?
|
Medicaid | 15 | 2020 | 2843 | 1.160 |
Why?
|
Health Care Surveys | 19 | 2016 | 2437 | 1.150 |
Why?
|
Information Dissemination | 7 | 2019 | 1138 | 1.110 |
Why?
|
Physicians | 12 | 2019 | 4615 | 1.070 |
Why?
|
Aged | 108 | 2024 | 171520 | 1.070 |
Why?
|
Hospitals, Proprietary | 3 | 2015 | 39 | 1.060 |
Why?
|
Water Pollutants, Chemical | 4 | 2024 | 363 | 1.060 |
Why?
|
Mortality | 9 | 2020 | 2917 | 1.050 |
Why?
|
Cost Control | 4 | 2017 | 627 | 1.040 |
Why?
|
Accreditation | 3 | 2018 | 478 | 1.030 |
Why?
|
Hip Fractures | 5 | 2021 | 996 | 1.030 |
Why?
|
Governing Board | 5 | 2015 | 50 | 1.020 |
Why?
|
Internationality | 4 | 2019 | 1007 | 1.000 |
Why?
|
Hospital Information Systems | 5 | 2013 | 394 | 1.000 |
Why?
|
Safety Management | 9 | 2015 | 764 | 0.990 |
Why?
|
Hemorrhagic Fever, Ebola | 5 | 2017 | 424 | 0.980 |
Why?
|
Aged, 80 and over | 55 | 2021 | 59680 | 0.950 |
Why?
|
Disease Outbreaks | 7 | 2024 | 1764 | 0.950 |
Why?
|
Chief Executive Officers, Hospital | 2 | 2014 | 9 | 0.940 |
Why?
|
Sharks | 1 | 2024 | 21 | 0.940 |
Why?
|
Hospitals, Urban | 4 | 2016 | 501 | 0.910 |
Why?
|
Communicable Disease Control | 4 | 2018 | 857 | 0.900 |
Why?
|
Octreotide | 2 | 2024 | 155 | 0.900 |
Why?
|
Economic Competition | 2 | 2017 | 223 | 0.890 |
Why?
|
Continuity of Patient Care | 4 | 2015 | 1076 | 0.890 |
Why?
|
Costs and Cost Analysis | 8 | 2023 | 1670 | 0.890 |
Why?
|
Ambulatory Care | 8 | 2020 | 2780 | 0.890 |
Why?
|
Male | 131 | 2024 | 364781 | 0.880 |
Why?
|
Female | 130 | 2024 | 396943 | 0.850 |
Why?
|
Patient Care | 4 | 2022 | 629 | 0.840 |
Why?
|
Attitude to Computers | 4 | 2015 | 196 | 0.830 |
Why?
|
Metals, Heavy | 1 | 2024 | 149 | 0.830 |
Why?
|
Practice Management, Medical | 4 | 2013 | 191 | 0.820 |
Why?
|
Medical Errors | 5 | 2013 | 1263 | 0.820 |
Why?
|
Minority Groups | 4 | 2017 | 1215 | 0.810 |
Why?
|
Clinical Competence | 5 | 2021 | 4841 | 0.790 |
Why?
|
Terminal Care | 5 | 2021 | 1773 | 0.790 |
Why?
|
Hospitals, Pediatric | 6 | 2017 | 1876 | 0.790 |
Why?
|
State Medicine | 3 | 2019 | 217 | 0.790 |
Why?
|
Ownership | 5 | 2016 | 343 | 0.780 |
Why?
|
Patient Participation | 7 | 2018 | 1450 | 0.780 |
Why?
|
Frail Elderly | 5 | 2021 | 774 | 0.770 |
Why?
|
Pancreatitis, Chronic | 2 | 2017 | 282 | 0.770 |
Why?
|
Salaries and Fringe Benefits | 2 | 2014 | 262 | 0.770 |
Why?
|
Program Evaluation | 7 | 2018 | 2508 | 0.760 |
Why?
|
Personnel Staffing and Scheduling | 3 | 2020 | 497 | 0.760 |
Why?
|
Brachial Plexus Neuritis | 1 | 2021 | 21 | 0.760 |
Why?
|
Patient Care Management | 2 | 2014 | 304 | 0.750 |
Why?
|
Cross Infection | 5 | 2013 | 1425 | 0.730 |
Why?
|
Public Health Practice | 1 | 2023 | 221 | 0.730 |
Why?
|
Health Services Research | 12 | 2018 | 1815 | 0.730 |
Why?
|
Pandemics | 7 | 2023 | 8753 | 0.710 |
Why?
|
Colonic Diseases | 2 | 2012 | 203 | 0.710 |
Why?
|
Emergency Service, Hospital | 6 | 2020 | 7956 | 0.710 |
Why?
|
Hepatitis E virus | 1 | 2021 | 72 | 0.690 |
Why?
|
Attitude of Health Personnel | 12 | 2018 | 3922 | 0.690 |
Why?
|
Hepatitis E | 1 | 2021 | 76 | 0.690 |
Why?
|
Reimbursement Mechanisms | 5 | 2019 | 677 | 0.680 |
Why?
|
Financial Management, Hospital | 2 | 2017 | 70 | 0.680 |
Why?
|
Patient-Centered Care | 4 | 2014 | 1439 | 0.670 |
Why?
|
Health Status Disparities | 8 | 2021 | 1876 | 0.660 |
Why?
|
Health Services Administration | 1 | 2020 | 63 | 0.660 |
Why?
|
Ambulatory Care Information Systems | 2 | 2012 | 89 | 0.660 |
Why?
|
Nursing Staff | 1 | 2020 | 113 | 0.660 |
Why?
|
Catheter-Related Infections | 2 | 2013 | 275 | 0.660 |
Why?
|
Public Health | 5 | 2021 | 2693 | 0.650 |
Why?
|
Chronic Disease | 10 | 2019 | 9382 | 0.650 |
Why?
|
Data Collection | 9 | 2016 | 3329 | 0.650 |
Why?
|
Community Health Planning | 1 | 2019 | 164 | 0.630 |
Why?
|
Primary Health Care | 9 | 2021 | 4737 | 0.630 |
Why?
|
Benchmarking | 5 | 2014 | 1058 | 0.630 |
Why?
|
Ventilators, Mechanical | 2 | 2022 | 292 | 0.630 |
Why?
|
Insurance, Health | 8 | 2022 | 2513 | 0.620 |
Why?
|
United States Environmental Protection Agency | 1 | 2019 | 139 | 0.620 |
Why?
|
Social Work | 1 | 2019 | 158 | 0.600 |
Why?
|
Trichuriasis | 1 | 2017 | 24 | 0.590 |
Why?
|
Disasters | 1 | 2024 | 523 | 0.590 |
Why?
|
Nuclear Medicine | 1 | 2021 | 259 | 0.590 |
Why?
|
Ochronosis | 1 | 2017 | 7 | 0.590 |
Why?
|
Alkaptonuria | 1 | 2017 | 13 | 0.580 |
Why?
|
Health Services for the Aged | 3 | 2011 | 258 | 0.580 |
Why?
|
Nuclear Medicine Department, Hospital | 1 | 2017 | 13 | 0.580 |
Why?
|
National Health Programs | 2 | 2018 | 442 | 0.580 |
Why?
|
Cesium Radioisotopes | 1 | 2017 | 38 | 0.570 |
Why?
|
Regional Health Planning | 2 | 2008 | 96 | 0.570 |
Why?
|
Insurance | 1 | 2019 | 115 | 0.570 |
Why?
|
Gamma Cameras | 1 | 2017 | 35 | 0.570 |
Why?
|
Practice Valuation and Purchase | 1 | 2017 | 1 | 0.570 |
Why?
|
Neuroma, Acoustic | 1 | 2021 | 458 | 0.570 |
Why?
|
Professional Practice Location | 1 | 2017 | 56 | 0.570 |
Why?
|
Sister Mary Joseph's Nodule | 1 | 2017 | 2 | 0.570 |
Why?
|
Australia | 6 | 2021 | 1264 | 0.570 |
Why?
|
International Cooperation | 7 | 2019 | 1439 | 0.570 |
Why?
|
Terminally Ill | 2 | 2021 | 240 | 0.570 |
Why?
|
Physicians' Offices | 2 | 2014 | 60 | 0.570 |
Why?
|
United States Federal Trade Commission | 1 | 2017 | 10 | 0.560 |
Why?
|
Retrospective Studies | 49 | 2023 | 81834 | 0.550 |
Why?
|
Facial Dermatoses | 1 | 2017 | 87 | 0.550 |
Why?
|
Patient Discharge | 9 | 2020 | 3471 | 0.550 |
Why?
|
Public Policy | 2 | 2019 | 560 | 0.550 |
Why?
|
Public Health Administration | 1 | 2019 | 242 | 0.540 |
Why?
|
Hospital Administrators | 1 | 2016 | 57 | 0.530 |
Why?
|
Physician Incentive Plans | 2 | 2014 | 164 | 0.530 |
Why?
|
International Agencies | 1 | 2017 | 245 | 0.520 |
Why?
|
Environmental Health | 1 | 2019 | 295 | 0.520 |
Why?
|
Neurilemmoma | 1 | 2021 | 524 | 0.520 |
Why?
|
Hospital Records | 2 | 2013 | 93 | 0.520 |
Why?
|
American Hospital Association | 5 | 2014 | 26 | 0.510 |
Why?
|
Artificial Intelligence | 2 | 2021 | 2659 | 0.510 |
Why?
|
Insurance Claim Review | 7 | 2018 | 745 | 0.510 |
Why?
|
Management Information Systems | 2 | 2008 | 49 | 0.510 |
Why?
|
Disabled Persons | 4 | 2018 | 1218 | 0.510 |
Why?
|
Marketing of Health Services | 1 | 2017 | 151 | 0.510 |
Why?
|
Cross-Sectional Studies | 20 | 2021 | 26351 | 0.500 |
Why?
|
Professional Practice | 1 | 2017 | 314 | 0.500 |
Why?
|
Meningeal Neoplasms | 2 | 2024 | 1251 | 0.500 |
Why?
|
Risk Adjustment | 8 | 2017 | 603 | 0.500 |
Why?
|
Preventive Medicine | 1 | 2017 | 245 | 0.490 |
Why?
|
Health Facility Closure | 1 | 2015 | 24 | 0.490 |
Why?
|
Medical Order Entry Systems | 4 | 2008 | 522 | 0.490 |
Why?
|
Gallbladder | 1 | 2017 | 308 | 0.490 |
Why?
|
Gallbladder Neoplasms | 1 | 2017 | 191 | 0.490 |
Why?
|
Meningioma | 1 | 2024 | 1222 | 0.490 |
Why?
|
Epidemics | 2 | 2019 | 517 | 0.480 |
Why?
|
Internal Medicine | 3 | 2017 | 1056 | 0.470 |
Why?
|
Poverty Areas | 2 | 2015 | 265 | 0.460 |
Why?
|
Europe | 7 | 2021 | 3439 | 0.460 |
Why?
|
Delegation, Professional | 1 | 2013 | 2 | 0.460 |
Why?
|
Health Facilities | 2 | 2017 | 576 | 0.450 |
Why?
|
Critical Care | 5 | 2015 | 2717 | 0.450 |
Why?
|
Triclosan | 2 | 2024 | 58 | 0.450 |
Why?
|
Poverty | 4 | 2020 | 2719 | 0.440 |
Why?
|
Schools, Medical | 2 | 2018 | 881 | 0.440 |
Why?
|
Surgery Department, Hospital | 3 | 2016 | 176 | 0.440 |
Why?
|
Cyprinidae | 2 | 2018 | 36 | 0.440 |
Why?
|
Conservation of Natural Resources | 1 | 2016 | 210 | 0.430 |
Why?
|
Drug Costs | 2 | 2021 | 1196 | 0.430 |
Why?
|
Fish Diseases | 3 | 2017 | 36 | 0.430 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2023 | 5426 | 0.430 |
Why?
|
Disease Transmission, Infectious | 1 | 2019 | 562 | 0.430 |
Why?
|
Information Systems | 3 | 2017 | 397 | 0.430 |
Why?
|
Respiratory Tract Diseases | 1 | 2019 | 749 | 0.430 |
Why?
|
Anti-HIV Agents | 2 | 2019 | 4567 | 0.430 |
Why?
|
Patient Admission | 2 | 2018 | 1370 | 0.430 |
Why?
|
United States Department of Veterans Affairs | 6 | 2014 | 937 | 0.420 |
Why?
|
Databases, Factual | 13 | 2020 | 8081 | 0.420 |
Why?
|
Hospitals, Public | 1 | 2014 | 205 | 0.420 |
Why?
|
Antimalarials | 1 | 2020 | 910 | 0.420 |
Why?
|
Uncompensated Care | 1 | 2013 | 37 | 0.420 |
Why?
|
General Surgery | 2 | 2018 | 1714 | 0.420 |
Why?
|
Radionuclide Imaging | 1 | 2017 | 1998 | 0.420 |
Why?
|
Nursing Homes | 1 | 2020 | 1084 | 0.410 |
Why?
|
Financing, Government | 2 | 2013 | 473 | 0.410 |
Why?
|
Academic Medical Centers | 5 | 2023 | 2785 | 0.410 |
Why?
|
Health Priorities | 1 | 2015 | 379 | 0.410 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3116 | 0.410 |
Why?
|
Adverse Drug Reaction Reporting Systems | 3 | 2008 | 495 | 0.400 |
Why?
|
Phantoms, Imaging | 2 | 2021 | 2528 | 0.400 |
Why?
|
Rate Setting and Review | 1 | 2012 | 41 | 0.400 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3240 | 0.400 |
Why?
|
Social Class | 3 | 2021 | 2000 | 0.400 |
Why?
|
Health Resources | 2 | 2015 | 950 | 0.400 |
Why?
|
Systems Integration | 3 | 2017 | 429 | 0.400 |
Why?
|
Length of Stay | 7 | 2019 | 6521 | 0.390 |
Why?
|
Lutetium | 2 | 2022 | 38 | 0.390 |
Why?
|
Socioeconomic Factors | 6 | 2019 | 7863 | 0.390 |
Why?
|
Colonoscopy | 2 | 2017 | 1412 | 0.380 |
Why?
|
Splenic Rupture | 1 | 2011 | 26 | 0.380 |
Why?
|
Abdomen | 2 | 2017 | 1136 | 0.380 |
Why?
|
Mandatory Reporting | 1 | 2012 | 123 | 0.380 |
Why?
|
Gram-Negative Bacterial Infections | 4 | 2017 | 238 | 0.380 |
Why?
|
Health Services Misuse | 2 | 2013 | 249 | 0.380 |
Why?
|
Organizational Innovation | 6 | 2017 | 540 | 0.380 |
Why?
|
Catfishes | 2 | 2024 | 14 | 0.380 |
Why?
|
Neoplasms | 8 | 2021 | 22386 | 0.380 |
Why?
|
Uncertainty | 1 | 2016 | 758 | 0.370 |
Why?
|
Medicare Part C | 1 | 2016 | 332 | 0.370 |
Why?
|
Out-of-Hospital Cardiac Arrest | 1 | 2015 | 340 | 0.370 |
Why?
|
Physician-Patient Relations | 3 | 2017 | 3267 | 0.370 |
Why?
|
State Health Plans | 1 | 2013 | 220 | 0.370 |
Why?
|
Mental Disorders | 2 | 2022 | 6879 | 0.370 |
Why?
|
Income | 6 | 2021 | 1878 | 0.370 |
Why?
|
Information Services | 2 | 2010 | 237 | 0.360 |
Why?
|
North America | 4 | 2021 | 1292 | 0.360 |
Why?
|
Leishmaniasis, Cutaneous | 1 | 2012 | 137 | 0.360 |
Why?
|
Coronary Artery Bypass | 6 | 2014 | 2194 | 0.360 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2023 | 2040 | 0.360 |
Why?
|
Multivariate Analysis | 12 | 2017 | 12096 | 0.360 |
Why?
|
Environmental Monitoring | 4 | 2024 | 1464 | 0.360 |
Why?
|
Nails | 1 | 2012 | 298 | 0.350 |
Why?
|
Nervous System Diseases | 1 | 2021 | 1668 | 0.350 |
Why?
|
Malaria | 1 | 2020 | 1240 | 0.340 |
Why?
|
Patients | 1 | 2016 | 909 | 0.340 |
Why?
|
Middle Aged | 48 | 2024 | 223418 | 0.340 |
Why?
|
Angioplasty | 1 | 2012 | 357 | 0.340 |
Why?
|
Physician Assistants | 1 | 2012 | 190 | 0.330 |
Why?
|
Organizational Policy | 1 | 2012 | 434 | 0.330 |
Why?
|
Office Visits | 2 | 2014 | 596 | 0.330 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2012 | 246 | 0.330 |
Why?
|
Regional Medical Programs | 1 | 2010 | 66 | 0.330 |
Why?
|
Lung Neoplasms | 3 | 2023 | 13589 | 0.330 |
Why?
|
Fingers | 1 | 2012 | 511 | 0.330 |
Why?
|
HIV Infections | 3 | 2022 | 17564 | 0.330 |
Why?
|
Residence Characteristics | 3 | 2021 | 2119 | 0.330 |
Why?
|
Natural Language Processing | 3 | 2023 | 1197 | 0.330 |
Why?
|
Liver Failure, Acute | 1 | 2011 | 182 | 0.320 |
Why?
|
Cervical Vertebrae | 1 | 2015 | 982 | 0.320 |
Why?
|
Education, Medical, Continuing | 1 | 2014 | 829 | 0.320 |
Why?
|
Linear Models | 7 | 2021 | 5880 | 0.320 |
Why?
|
Nurse Practitioners | 1 | 2012 | 271 | 0.320 |
Why?
|
Liver Failure | 1 | 2011 | 252 | 0.320 |
Why?
|
Wuchereria bancrofti | 1 | 2008 | 20 | 0.310 |
Why?
|
Spinal Fractures | 1 | 2015 | 712 | 0.310 |
Why?
|
Filariasis | 1 | 2008 | 26 | 0.310 |
Why?
|
Gross Domestic Product | 2 | 2019 | 77 | 0.310 |
Why?
|
Confidence Intervals | 4 | 2019 | 2932 | 0.310 |
Why?
|
Medical Informatics Applications | 1 | 2010 | 180 | 0.310 |
Why?
|
Policy Making | 4 | 2018 | 545 | 0.310 |
Why?
|
Access to Information | 1 | 2011 | 317 | 0.310 |
Why?
|
Efficiency | 1 | 2011 | 477 | 0.310 |
Why?
|
Mental Health Services | 1 | 2020 | 1732 | 0.300 |
Why?
|
Point-of-Care Systems | 2 | 2017 | 1228 | 0.300 |
Why?
|
India | 4 | 2019 | 2323 | 0.300 |
Why?
|
Inpatients | 2 | 2017 | 2561 | 0.300 |
Why?
|
Nepal | 3 | 2019 | 301 | 0.300 |
Why?
|
Breast Neoplasms, Male | 1 | 2010 | 212 | 0.300 |
Why?
|
Organizational Culture | 1 | 2011 | 510 | 0.300 |
Why?
|
Intestinal Obstruction | 1 | 2012 | 435 | 0.300 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2022 | 9066 | 0.300 |
Why?
|
Postoperative Complications | 8 | 2018 | 15880 | 0.290 |
Why?
|
Logistic Models | 11 | 2020 | 13324 | 0.290 |
Why?
|
Health Records, Personal | 1 | 2009 | 127 | 0.290 |
Why?
|
Surface-Active Agents | 1 | 2008 | 152 | 0.290 |
Why?
|
Respiratory Burst | 2 | 2007 | 110 | 0.290 |
Why?
|
Medication Systems, Hospital | 1 | 2008 | 154 | 0.290 |
Why?
|
Canada | 3 | 2019 | 2143 | 0.290 |
Why?
|
Accidental Falls | 1 | 2015 | 1081 | 0.290 |
Why?
|
Risk Assessment | 12 | 2024 | 24311 | 0.280 |
Why?
|
Esophagectomy | 1 | 2011 | 482 | 0.280 |
Why?
|
Massachusetts | 8 | 2019 | 8908 | 0.280 |
Why?
|
Geologic Sediments | 2 | 2024 | 82 | 0.280 |
Why?
|
Chickenpox | 1 | 2007 | 96 | 0.280 |
Why?
|
Pancytopenia | 1 | 2008 | 102 | 0.280 |
Why?
|
Rare Diseases | 1 | 2012 | 630 | 0.270 |
Why?
|
Diagnosis-Related Groups | 5 | 2014 | 448 | 0.270 |
Why?
|
Cesarean Section | 1 | 2015 | 1414 | 0.270 |
Why?
|
Adult | 37 | 2024 | 223542 | 0.270 |
Why?
|
Odds Ratio | 8 | 2018 | 9687 | 0.270 |
Why?
|
Sex Factors | 6 | 2021 | 10647 | 0.270 |
Why?
|
Peripheral Vascular Diseases | 1 | 2009 | 489 | 0.270 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2014 | 952 | 0.270 |
Why?
|
Pneumonia, Pneumococcal | 1 | 2007 | 134 | 0.270 |
Why?
|
Adenocarcinoma | 4 | 2017 | 6400 | 0.270 |
Why?
|
State Government | 3 | 2019 | 389 | 0.270 |
Why?
|
Esophageal and Gastric Varices | 2 | 2018 | 212 | 0.260 |
Why?
|
Influenza, Human | 3 | 2018 | 1540 | 0.260 |
Why?
|
Africa | 3 | 2019 | 726 | 0.260 |
Why?
|
Cross-Cultural Comparison | 2 | 2021 | 639 | 0.260 |
Why?
|
Disclosure | 2 | 2016 | 750 | 0.260 |
Why?
|
Information Storage and Retrieval | 1 | 2011 | 823 | 0.260 |
Why?
|
Industry | 1 | 2008 | 366 | 0.260 |
Why?
|
Rehabilitation Centers | 2 | 2021 | 250 | 0.250 |
Why?
|
Activities of Daily Living | 1 | 2015 | 2433 | 0.250 |
Why?
|
Appointments and Schedules | 1 | 2009 | 443 | 0.250 |
Why?
|
Minerals | 2 | 2024 | 282 | 0.250 |
Why?
|
Receptors, Peptide | 2 | 2024 | 280 | 0.250 |
Why?
|
Arterial Occlusive Diseases | 1 | 2009 | 751 | 0.250 |
Why?
|
Cohort Studies | 13 | 2023 | 41797 | 0.250 |
Why?
|
Population Surveillance | 2 | 2013 | 2601 | 0.240 |
Why?
|
Health Benefit Plans, Employee | 1 | 2008 | 332 | 0.240 |
Why?
|
Critical Illness | 1 | 2018 | 2754 | 0.240 |
Why?
|
Herpes Zoster | 1 | 2007 | 253 | 0.240 |
Why?
|
Diagnostic Tests, Routine | 2 | 2009 | 792 | 0.240 |
Why?
|
Workload | 1 | 2011 | 852 | 0.240 |
Why?
|
Episode of Care | 2 | 2016 | 128 | 0.240 |
Why?
|
Diabetes Mellitus | 4 | 2021 | 5887 | 0.240 |
Why?
|
Medicine | 1 | 2013 | 946 | 0.240 |
Why?
|
Immunization Programs | 1 | 2007 | 267 | 0.240 |
Why?
|
Evidence-Based Medicine | 3 | 2017 | 3708 | 0.240 |
Why?
|
Infection Control | 1 | 2012 | 985 | 0.240 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2291 | 0.240 |
Why?
|
Tuberculosis, Miliary | 1 | 2004 | 13 | 0.230 |
Why?
|
Adjuvants, Immunologic | 2 | 2007 | 998 | 0.230 |
Why?
|
Leg | 1 | 2009 | 1089 | 0.230 |
Why?
|
Colon | 1 | 2012 | 1804 | 0.230 |
Why?
|
Yttrium | 1 | 2024 | 33 | 0.230 |
Why?
|
Rivers | 1 | 2024 | 67 | 0.230 |
Why?
|
Federal Government | 2 | 2017 | 266 | 0.230 |
Why?
|
Medically Uninsured | 3 | 2015 | 841 | 0.230 |
Why?
|
Dietary Supplements | 3 | 2018 | 3445 | 0.230 |
Why?
|
Developing Countries | 4 | 2020 | 2901 | 0.220 |
Why?
|
Hospice Care | 2 | 2022 | 679 | 0.220 |
Why?
|
Health Services | 2 | 2020 | 756 | 0.220 |
Why?
|
Emergency Medical Services | 1 | 2015 | 1948 | 0.220 |
Why?
|
Health Personnel | 4 | 2020 | 3384 | 0.220 |
Why?
|
Age Factors | 6 | 2018 | 18478 | 0.210 |
Why?
|
Total Quality Management | 1 | 2004 | 264 | 0.210 |
Why?
|
Treatment Outcome | 19 | 2024 | 65409 | 0.210 |
Why?
|
Risk | 4 | 2020 | 9642 | 0.210 |
Why?
|
Attitude to Health | 3 | 2008 | 2030 | 0.210 |
Why?
|
Immunity, Innate | 3 | 2018 | 3080 | 0.210 |
Why?
|
Confidentiality | 3 | 2019 | 606 | 0.200 |
Why?
|
Trace Elements | 1 | 2024 | 193 | 0.200 |
Why?
|
Colonic Neoplasms | 2 | 2012 | 2544 | 0.200 |
Why?
|
Still's Disease, Adult-Onset | 1 | 2002 | 23 | 0.200 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2010 | 1092 | 0.200 |
Why?
|
Intensive Care Units | 4 | 2021 | 3805 | 0.200 |
Why?
|
Medication Errors | 1 | 2008 | 783 | 0.200 |
Why?
|
Lypressin | 2 | 2018 | 26 | 0.200 |
Why?
|
Glutathione Transferase | 1 | 2024 | 567 | 0.200 |
Why?
|
Fever of Unknown Origin | 1 | 2002 | 94 | 0.200 |
Why?
|
Time Factors | 14 | 2020 | 40271 | 0.190 |
Why?
|
Rectal Neoplasms | 3 | 2017 | 1179 | 0.190 |
Why?
|
Radioimmunotherapy | 1 | 2021 | 93 | 0.190 |
Why?
|
Tomography, X-Ray Computed | 3 | 2021 | 20762 | 0.190 |
Why?
|
Rectal Fistula | 1 | 2021 | 76 | 0.190 |
Why?
|
Carcinoma | 2 | 2023 | 2341 | 0.190 |
Why?
|
Insurance Carriers | 2 | 2022 | 158 | 0.180 |
Why?
|
Health Services Needs and Demand | 2 | 2021 | 1408 | 0.180 |
Why?
|
Cranial Nerves | 1 | 2021 | 98 | 0.180 |
Why?
|
Fluorescein | 1 | 2021 | 175 | 0.180 |
Why?
|
Acute Disease | 5 | 2018 | 7246 | 0.180 |
Why?
|
Hot Temperature | 2 | 2018 | 1439 | 0.180 |
Why?
|
Physicians, Women | 2 | 2017 | 519 | 0.180 |
Why?
|
Politics | 2 | 2018 | 821 | 0.180 |
Why?
|
Esophageal Neoplasms | 1 | 2011 | 1676 | 0.180 |
Why?
|
Models, Organizational | 3 | 2018 | 546 | 0.180 |
Why?
|
Vascular Surgical Procedures | 1 | 2009 | 1509 | 0.180 |
Why?
|
Cost of Illness | 4 | 2020 | 1960 | 0.180 |
Why?
|
Medication Adherence | 1 | 2012 | 2190 | 0.180 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2007 | 1359 | 0.180 |
Why?
|
Models, Economic | 3 | 2016 | 717 | 0.180 |
Why?
|
Clinical Laboratory Information Systems | 3 | 2008 | 108 | 0.180 |
Why?
|
Cystatin C | 1 | 2022 | 272 | 0.180 |
Why?
|
Organometallic Compounds | 1 | 2024 | 649 | 0.170 |
Why?
|
Nursing Staff, Hospital | 2 | 2017 | 350 | 0.170 |
Why?
|
Prostate-Specific Antigen | 2 | 2022 | 2483 | 0.170 |
Why?
|
Sepsis | 2 | 2011 | 2602 | 0.170 |
Why?
|
Dipeptides | 1 | 2022 | 386 | 0.170 |
Why?
|
Ecosystem | 1 | 2024 | 494 | 0.170 |
Why?
|
Managed Care Programs | 2 | 2017 | 941 | 0.170 |
Why?
|
Diagnosis, Differential | 7 | 2017 | 13026 | 0.170 |
Why?
|
Radiometry | 2 | 2022 | 816 | 0.170 |
Why?
|
Thoracic Surgery | 1 | 2006 | 727 | 0.170 |
Why?
|
Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2019 | 43 | 0.170 |
Why?
|
Dust | 1 | 2022 | 488 | 0.170 |
Why?
|
Internet | 1 | 2012 | 3123 | 0.170 |
Why?
|
Liver Abscess, Amebic | 1 | 2019 | 19 | 0.160 |
Why?
|
Medical Oncology | 2 | 2022 | 2347 | 0.160 |
Why?
|
Forecasting | 4 | 2013 | 2950 | 0.160 |
Why?
|
Chi-Square Distribution | 4 | 2009 | 3438 | 0.160 |
Why?
|
Survival Analysis | 6 | 2017 | 10125 | 0.160 |
Why?
|
Geriatric Assessment | 2 | 2018 | 1422 | 0.160 |
Why?
|
Acute Kidney Injury | 2 | 2022 | 1943 | 0.160 |
Why?
|
Ancillary Services, Hospital | 1 | 1998 | 23 | 0.160 |
Why?
|
Joint Commission on Accreditation of Healthcare Organizations | 1 | 2018 | 91 | 0.150 |
Why?
|
Locomotion | 1 | 2021 | 391 | 0.150 |
Why?
|
Prospective Payment System | 2 | 2017 | 136 | 0.150 |
Why?
|
Government Programs | 1 | 2020 | 278 | 0.150 |
Why?
|
Chordoma | 1 | 2021 | 350 | 0.150 |
Why?
|
Risk Factors | 13 | 2018 | 74915 | 0.150 |
Why?
|
Government Regulation | 2 | 2020 | 525 | 0.150 |
Why?
|
Colon, Ascending | 1 | 2017 | 14 | 0.150 |
Why?
|
Phenylketonurias | 1 | 2019 | 129 | 0.150 |
Why?
|
Skull Base Neoplasms | 1 | 2021 | 281 | 0.150 |
Why?
|
World Health Organization | 3 | 2024 | 1328 | 0.150 |
Why?
|
Accidents, Occupational | 1 | 2019 | 252 | 0.150 |
Why?
|
Trichuris | 1 | 2017 | 32 | 0.150 |
Why?
|
Security Measures | 1 | 2018 | 83 | 0.150 |
Why?
|
Public Sector | 1 | 2019 | 265 | 0.150 |
Why?
|
Antigens, Surface | 1 | 2022 | 1615 | 0.150 |
Why?
|
Video-Assisted Surgery | 1 | 2017 | 51 | 0.140 |
Why?
|
Social Conditions | 1 | 2018 | 121 | 0.140 |
Why?
|
Steatorrhea | 1 | 2017 | 5 | 0.140 |
Why?
|
Bone Marrow | 1 | 2008 | 2929 | 0.140 |
Why?
|
Proctoscopy | 1 | 2017 | 40 | 0.140 |
Why?
|
Brachial Plexus Neuropathies | 1 | 2019 | 124 | 0.140 |
Why?
|
Financing, Personal | 1 | 2020 | 310 | 0.140 |
Why?
|
Computer Systems | 2 | 1998 | 470 | 0.140 |
Why?
|
Mass Screening | 2 | 2017 | 5455 | 0.140 |
Why?
|
Spinal Cord Neoplasms | 1 | 2019 | 263 | 0.140 |
Why?
|
Young Adult | 11 | 2020 | 60045 | 0.140 |
Why?
|
End Stage Liver Disease | 1 | 2022 | 370 | 0.140 |
Why?
|
Radiopharmaceuticals | 2 | 2024 | 2731 | 0.140 |
Why?
|
Drug Monitoring | 2 | 2001 | 964 | 0.140 |
Why?
|
Guideline Adherence | 3 | 2017 | 2239 | 0.140 |
Why?
|
California | 2 | 2019 | 1444 | 0.140 |
Why?
|
Anus Neoplasms | 1 | 2021 | 338 | 0.140 |
Why?
|
Cecum | 1 | 2017 | 232 | 0.140 |
Why?
|
Breast Neoplasms | 6 | 2022 | 21156 | 0.140 |
Why?
|
Dermoscopy | 1 | 2017 | 72 | 0.140 |
Why?
|
Organizational Affiliation | 1 | 2016 | 34 | 0.140 |
Why?
|
Pancreatic Pseudocyst | 1 | 2017 | 112 | 0.140 |
Why?
|
Veterans | 2 | 2007 | 2671 | 0.140 |
Why?
|
Organizational Case Studies | 1 | 2017 | 301 | 0.140 |
Why?
|
Neuroendocrine Tumors | 1 | 2023 | 649 | 0.140 |
Why?
|
Hospital Charges | 2 | 2014 | 351 | 0.130 |
Why?
|
Radioisotopes | 3 | 2023 | 516 | 0.130 |
Why?
|
Emigration and Immigration | 1 | 2019 | 405 | 0.130 |
Why?
|
Health Surveys | 3 | 2020 | 4056 | 0.130 |
Why?
|
Disease Management | 2 | 2019 | 2533 | 0.130 |
Why?
|
Melanosis | 1 | 2017 | 93 | 0.130 |
Why?
|
Hypertension, Portal | 1 | 2018 | 229 | 0.130 |
Why?
|
Penile Neoplasms | 1 | 2017 | 165 | 0.130 |
Why?
|
Adolescent | 15 | 2020 | 89168 | 0.130 |
Why?
|
Cause of Death | 2 | 2018 | 3727 | 0.130 |
Why?
|
Tryptophan | 1 | 2018 | 483 | 0.130 |
Why?
|
Models, Statistical | 2 | 2008 | 5103 | 0.130 |
Why?
|
Motivation | 3 | 2013 | 2034 | 0.130 |
Why?
|
Gastrointestinal Hemorrhage | 3 | 2018 | 1126 | 0.130 |
Why?
|
Child | 10 | 2020 | 80863 | 0.130 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2007 | 2181 | 0.130 |
Why?
|
Societies, Hospital | 1 | 2015 | 6 | 0.130 |
Why?
|
Telemedicine | 1 | 2013 | 3104 | 0.130 |
Why?
|
Survival Rate | 3 | 2021 | 12875 | 0.130 |
Why?
|
Laparoscopy | 2 | 2017 | 2056 | 0.120 |
Why?
|
Outpatients | 1 | 2023 | 1607 | 0.120 |
Why?
|
Poisson Distribution | 1 | 2017 | 509 | 0.120 |
Why?
|
Iatrogenic Disease | 1 | 2019 | 552 | 0.120 |
Why?
|
Algorithms | 6 | 2022 | 14158 | 0.120 |
Why?
|
Prospective Studies | 10 | 2023 | 54914 | 0.120 |
Why?
|
Pregnancy, High-Risk | 1 | 2015 | 121 | 0.120 |
Why?
|
Investments | 2 | 2015 | 149 | 0.120 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2023 | 959 | 0.120 |
Why?
|
Transportation | 1 | 2017 | 218 | 0.120 |
Why?
|
Quality of Life | 4 | 2023 | 13497 | 0.120 |
Why?
|
Utilization Review | 2 | 2013 | 384 | 0.120 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2015 | 76 | 0.120 |
Why?
|
Administrative Personnel | 1 | 2016 | 185 | 0.120 |
Why?
|
Health Care Sector | 1 | 2017 | 196 | 0.120 |
Why?
|
E-Selectin | 1 | 2017 | 578 | 0.120 |
Why?
|
Animal Feed | 3 | 2017 | 110 | 0.120 |
Why?
|
Vasoconstrictor Agents | 1 | 2018 | 658 | 0.120 |
Why?
|
Growth Charts | 1 | 2015 | 60 | 0.120 |
Why?
|
Demography | 1 | 2019 | 1643 | 0.120 |
Why?
|
Equipment Failure Analysis | 1 | 2017 | 848 | 0.120 |
Why?
|
Research | 3 | 2019 | 1984 | 0.120 |
Why?
|
International Classification of Diseases | 2 | 2018 | 925 | 0.120 |
Why?
|
Child, Preschool | 7 | 2020 | 42623 | 0.120 |
Why?
|
Achievement | 1 | 2016 | 288 | 0.120 |
Why?
|
Prevalence | 3 | 2019 | 15880 | 0.120 |
Why?
|
Geography | 1 | 2016 | 654 | 0.110 |
Why?
|
Long-Term Care | 1 | 2018 | 633 | 0.110 |
Why?
|
Science | 1 | 2017 | 239 | 0.110 |
Why?
|
Liver Cirrhosis | 2 | 2020 | 1950 | 0.110 |
Why?
|
Clinical Coding | 1 | 2015 | 186 | 0.110 |
Why?
|
Health Maintenance Organizations | 1 | 2017 | 658 | 0.110 |
Why?
|
Mediastinitis | 1 | 2013 | 49 | 0.110 |
Why?
|
Embolization, Therapeutic | 1 | 2024 | 1435 | 0.110 |
Why?
|
Curcumin | 1 | 2015 | 98 | 0.110 |
Why?
|
Central Nervous System | 1 | 2021 | 1348 | 0.110 |
Why?
|
Infant | 7 | 2020 | 36497 | 0.110 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2021 | 4083 | 0.110 |
Why?
|
Communication Barriers | 1 | 2017 | 419 | 0.110 |
Why?
|
Hospices | 1 | 2016 | 245 | 0.110 |
Why?
|
Drug Combinations | 1 | 2019 | 2079 | 0.110 |
Why?
|
Fatal Outcome | 2 | 2011 | 1840 | 0.110 |
Why?
|
Stroke | 2 | 2015 | 9791 | 0.110 |
Why?
|
Interinstitutional Relations | 1 | 2014 | 236 | 0.110 |
Why?
|
Community-Acquired Infections | 1 | 2017 | 473 | 0.110 |
Why?
|
Registries | 3 | 2021 | 8373 | 0.110 |
Why?
|
Drainage | 1 | 2019 | 1179 | 0.110 |
Why?
|
Radiation Dosage | 1 | 2021 | 1973 | 0.110 |
Why?
|
Radiotherapy | 1 | 2019 | 1510 | 0.100 |
Why?
|
Group Practice | 2 | 2011 | 151 | 0.100 |
Why?
|
Social Security | 1 | 2013 | 101 | 0.100 |
Why?
|
Zinc | 1 | 2017 | 677 | 0.100 |
Why?
|
Necrosis | 1 | 2017 | 1621 | 0.100 |
Why?
|
Severity of Illness Index | 3 | 2022 | 15965 | 0.100 |
Why?
|
Vulnerable Populations | 1 | 2018 | 717 | 0.100 |
Why?
|
Legislation, Hospital | 1 | 2012 | 11 | 0.100 |
Why?
|
Economics | 1 | 2013 | 141 | 0.100 |
Why?
|
Parity | 1 | 2015 | 939 | 0.100 |
Why?
|
Organizational Objectives | 1 | 2014 | 427 | 0.100 |
Why?
|
Organizations | 1 | 2013 | 172 | 0.100 |
Why?
|
Health Status | 3 | 2018 | 4096 | 0.100 |
Why?
|
Fever | 1 | 2020 | 1622 | 0.100 |
Why?
|
Prognosis | 6 | 2023 | 30028 | 0.100 |
Why?
|
Antiprotozoal Agents | 1 | 2012 | 95 | 0.100 |
Why?
|
Phosphorylcholine | 1 | 2012 | 153 | 0.100 |
Why?
|
Advance Care Planning | 1 | 2019 | 698 | 0.100 |
Why?
|
Denmark | 1 | 2014 | 778 | 0.100 |
Why?
|
Follow-Up Studies | 9 | 2021 | 39430 | 0.100 |
Why?
|
Injury Severity Score | 1 | 2015 | 1053 | 0.100 |
Why?
|
Republic of Korea | 1 | 2014 | 587 | 0.100 |
Why?
|
Leishmaniasis, Visceral | 1 | 2012 | 100 | 0.100 |
Why?
|
Biopsy, Fine-Needle | 1 | 2017 | 1131 | 0.100 |
Why?
|
Age Distribution | 2 | 2007 | 2881 | 0.090 |
Why?
|
Reproducibility of Results | 4 | 2021 | 20231 | 0.090 |
Why?
|
Viral Vaccines | 1 | 2017 | 596 | 0.090 |
Why?
|
Lymph Node Excision | 1 | 2017 | 1276 | 0.090 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2007 | 1244 | 0.090 |
Why?
|
Radiation Injuries | 1 | 2019 | 1205 | 0.090 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2015 | 656 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2024 | 2331 | 0.090 |
Why?
|
Program Development | 2 | 2018 | 1296 | 0.090 |
Why?
|
Communicable Diseases | 1 | 2019 | 875 | 0.090 |
Why?
|
Life Expectancy | 1 | 2018 | 1249 | 0.090 |
Why?
|
Japan | 1 | 2015 | 1418 | 0.090 |
Why?
|
Lead | 1 | 2017 | 880 | 0.090 |
Why?
|
Bronchiolitis | 1 | 2017 | 492 | 0.090 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2015 | 624 | 0.090 |
Why?
|
Duodenal Neoplasms | 1 | 2011 | 114 | 0.090 |
Why?
|
Malpractice | 1 | 2015 | 561 | 0.090 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2021 | 1418 | 0.090 |
Why?
|
Rupture, Spontaneous | 1 | 2011 | 365 | 0.090 |
Why?
|
Ultrasonography, Interventional | 1 | 2019 | 1519 | 0.090 |
Why?
|
Goals | 1 | 2016 | 715 | 0.090 |
Why?
|
Aeromonas hydrophila | 2 | 2007 | 9 | 0.090 |
Why?
|
Genomic Instability | 1 | 2015 | 714 | 0.090 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2021 | 1401 | 0.090 |
Why?
|
Random Allocation | 3 | 2017 | 2399 | 0.090 |
Why?
|
Private Practice | 1 | 2011 | 155 | 0.090 |
Why?
|
Cost-Benefit Analysis | 5 | 2024 | 5532 | 0.090 |
Why?
|
Diabetes Complications | 1 | 2017 | 1322 | 0.090 |
Why?
|
Employment | 1 | 2016 | 1120 | 0.090 |
Why?
|
Bacteremia | 2 | 2012 | 985 | 0.090 |
Why?
|
Biopsy | 2 | 2012 | 6816 | 0.080 |
Why?
|
Muramidase | 2 | 2007 | 165 | 0.080 |
Why?
|
Trauma Centers | 1 | 2015 | 950 | 0.080 |
Why?
|
Software | 2 | 2023 | 4463 | 0.080 |
Why?
|
Splenectomy | 1 | 2011 | 392 | 0.080 |
Why?
|
Viral Load | 1 | 2019 | 3399 | 0.080 |
Why?
|
Referral and Consultation | 2 | 2017 | 3629 | 0.080 |
Why?
|
Electronic Prescribing | 1 | 2010 | 114 | 0.080 |
Why?
|
Animals | 12 | 2024 | 169418 | 0.080 |
Why?
|
Interdisciplinary Communication | 2 | 2016 | 937 | 0.080 |
Why?
|
Hospitals, General | 2 | 2011 | 807 | 0.080 |
Why?
|
Medically Underserved Area | 1 | 2011 | 266 | 0.080 |
Why?
|
Therapeutic Human Experimentation | 1 | 2009 | 43 | 0.080 |
Why?
|
Disease Progression | 2 | 2024 | 13655 | 0.080 |
Why?
|
Radiology | 1 | 2023 | 2118 | 0.080 |
Why?
|
Health Plan Implementation | 1 | 2012 | 338 | 0.080 |
Why?
|
Australasia | 1 | 2008 | 21 | 0.080 |
Why?
|
Equipment Design | 1 | 2017 | 3530 | 0.080 |
Why?
|
Coronary Disease | 1 | 2003 | 5926 | 0.080 |
Why?
|
Cetrimonium Compounds | 1 | 2008 | 4 | 0.080 |
Why?
|
Neoplasm Staging | 5 | 2021 | 11249 | 0.080 |
Why?
|
Travel | 1 | 2015 | 800 | 0.080 |
Why?
|
Needs Assessment | 1 | 2015 | 1146 | 0.080 |
Why?
|
Lung | 2 | 2023 | 10090 | 0.080 |
Why?
|
Air Pollutants | 1 | 2022 | 2905 | 0.080 |
Why?
|
Statistics as Topic | 2 | 2011 | 2362 | 0.080 |
Why?
|
Financial Management | 1 | 2010 | 161 | 0.080 |
Why?
|
Clinical Pharmacy Information Systems | 1 | 2008 | 102 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 12242 | 0.080 |
Why?
|
Calcinosis | 1 | 2017 | 1485 | 0.080 |
Why?
|
Anemia, Megaloblastic | 1 | 2008 | 24 | 0.080 |
Why?
|
Diagnostic Errors | 1 | 2015 | 1282 | 0.070 |
Why?
|
Neutrons | 1 | 2008 | 78 | 0.070 |
Why?
|
Polystyrenes | 1 | 2008 | 105 | 0.070 |
Why?
|
Adsorption | 1 | 2008 | 198 | 0.070 |
Why?
|
Standard of Care | 1 | 2012 | 571 | 0.070 |
Why?
|
Diagnostic Imaging | 1 | 2022 | 3543 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2024 | 4362 | 0.070 |
Why?
|
Spinal Cord Injuries | 1 | 2015 | 928 | 0.070 |
Why?
|
Pneumonia, Bacterial | 1 | 2010 | 319 | 0.070 |
Why?
|
Cations | 1 | 2008 | 240 | 0.070 |
Why?
|
Bone Marrow Examination | 1 | 2008 | 155 | 0.070 |
Why?
|
Health Care Coalitions | 1 | 2007 | 36 | 0.070 |
Why?
|
Neurosurgical Procedures | 1 | 2019 | 2097 | 0.070 |
Why?
|
Physicians, Family | 1 | 2009 | 349 | 0.070 |
Why?
|
Entropy | 1 | 2008 | 212 | 0.070 |
Why?
|
Immunocompetence | 1 | 2007 | 139 | 0.070 |
Why?
|
Benzenesulfonates | 1 | 2008 | 166 | 0.070 |
Why?
|
Micelles | 1 | 2008 | 192 | 0.070 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2015 | 997 | 0.070 |
Why?
|
Language | 1 | 2017 | 1557 | 0.070 |
Why?
|
Anemia | 1 | 2017 | 1521 | 0.070 |
Why?
|
Computer Simulation | 1 | 2021 | 6278 | 0.070 |
Why?
|
Prostatic Neoplasms | 2 | 2022 | 11206 | 0.070 |
Why?
|
Cerebrovascular Disorders | 1 | 2014 | 1487 | 0.070 |
Why?
|
Death | 2 | 2022 | 683 | 0.070 |
Why?
|
Pressure Ulcer | 1 | 2008 | 159 | 0.070 |
Why?
|
Fructans | 1 | 2006 | 4 | 0.070 |
Why?
|
Carps | 1 | 2006 | 51 | 0.070 |
Why?
|
Erythrocyte Count | 1 | 2007 | 157 | 0.070 |
Why?
|
Leadership | 1 | 2016 | 1395 | 0.070 |
Why?
|
Thermodynamics | 1 | 2008 | 594 | 0.070 |
Why?
|
Scattering, Radiation | 1 | 2008 | 491 | 0.070 |
Why?
|
RNA, Fungal | 1 | 2007 | 156 | 0.070 |
Why?
|
Education, Medical | 1 | 2018 | 1742 | 0.070 |
Why?
|
Pain | 2 | 2017 | 5096 | 0.070 |
Why?
|
Urinary Tract Infections | 1 | 2012 | 806 | 0.070 |
Why?
|
Resuscitation Orders | 1 | 2008 | 271 | 0.060 |
Why?
|
Alcoholism | 1 | 2017 | 1993 | 0.060 |
Why?
|
Neoplasm Metastasis | 1 | 2017 | 4931 | 0.060 |
Why?
|
Patient Selection | 1 | 2018 | 4266 | 0.060 |
Why?
|
Myocardial Reperfusion | 1 | 2007 | 339 | 0.060 |
Why?
|
Michigan | 1 | 2006 | 341 | 0.060 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14728 | 0.060 |
Why?
|
Research Design | 1 | 2021 | 6217 | 0.060 |
Why?
|
Anemia, Aplastic | 1 | 2008 | 231 | 0.060 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 1557 | 0.060 |
Why?
|
Creatinine | 2 | 2022 | 1915 | 0.060 |
Why?
|
Aspirin | 2 | 2007 | 3139 | 0.060 |
Why?
|
beta Carotene | 1 | 2007 | 523 | 0.060 |
Why?
|
Public Health Informatics | 1 | 2006 | 109 | 0.060 |
Why?
|
Physician's Role | 1 | 2012 | 927 | 0.060 |
Why?
|
Surface Properties | 1 | 2008 | 1168 | 0.060 |
Why?
|
Information Management | 1 | 2005 | 100 | 0.060 |
Why?
|
Ecotoxicology | 1 | 2024 | 8 | 0.060 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2011 | 887 | 0.060 |
Why?
|
Incidence | 2 | 2015 | 21552 | 0.060 |
Why?
|
Democratic Republic of the Congo | 1 | 2024 | 87 | 0.060 |
Why?
|
Gills | 1 | 2024 | 21 | 0.060 |
Why?
|
Infant, Newborn | 3 | 2020 | 26395 | 0.060 |
Why?
|
United States Agency for Healthcare Research and Quality | 1 | 2004 | 86 | 0.060 |
Why?
|
Monkeypox virus | 1 | 2024 | 43 | 0.060 |
Why?
|
Philosophy, Medical | 1 | 2004 | 79 | 0.060 |
Why?
|
Surgical Wound Infection | 1 | 2013 | 1544 | 0.060 |
Why?
|
Cytodiagnosis | 1 | 2008 | 452 | 0.060 |
Why?
|
Pancreatitis | 1 | 2011 | 1087 | 0.060 |
Why?
|
Fresh Water | 1 | 2024 | 85 | 0.060 |
Why?
|
Probability | 1 | 2009 | 2483 | 0.060 |
Why?
|
Predictive Value of Tests | 3 | 2016 | 15460 | 0.060 |
Why?
|
Communication | 1 | 2018 | 3910 | 0.060 |
Why?
|
Catalase | 1 | 2024 | 219 | 0.060 |
Why?
|
Hemoglobins | 2 | 2007 | 1532 | 0.060 |
Why?
|
Career Mobility | 1 | 2006 | 262 | 0.060 |
Why?
|
Jaundice | 1 | 2004 | 95 | 0.060 |
Why?
|
New York | 1 | 2006 | 882 | 0.050 |
Why?
|
Physical Examination | 1 | 2009 | 1262 | 0.050 |
Why?
|
Pneumococcal Vaccines | 1 | 2007 | 414 | 0.050 |
Why?
|
Promoter Regions, Genetic | 1 | 2015 | 5803 | 0.050 |
Why?
|
Databases as Topic | 1 | 2005 | 475 | 0.050 |
Why?
|
Models, Theoretical | 2 | 2013 | 3590 | 0.050 |
Why?
|
Clinical Laboratory Techniques | 2 | 1999 | 749 | 0.050 |
Why?
|
Incidental Findings | 1 | 2008 | 699 | 0.050 |
Why?
|
Yttrium Radioisotopes | 1 | 2024 | 114 | 0.050 |
Why?
|
Proportional Hazards Models | 3 | 2021 | 12561 | 0.050 |
Why?
|
Analysis of Variance | 2 | 2011 | 6242 | 0.050 |
Why?
|
Leukocyte Count | 1 | 2007 | 1604 | 0.050 |
Why?
|
England | 2 | 2015 | 533 | 0.050 |
Why?
|
Ligands | 2 | 2022 | 3281 | 0.050 |
Why?
|
Neoplasm Proteins | 1 | 2015 | 3611 | 0.050 |
Why?
|
Commerce | 1 | 2008 | 613 | 0.050 |
Why?
|
Mental Health | 1 | 2017 | 3271 | 0.050 |
Why?
|
Antineoplastic Agents | 3 | 2019 | 13708 | 0.050 |
Why?
|
Confusion | 1 | 2004 | 278 | 0.050 |
Why?
|
Liver | 3 | 2024 | 7575 | 0.050 |
Why?
|
Sex Distribution | 1 | 2007 | 2286 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 5342 | 0.050 |
Why?
|
Heterocyclic Compounds, 1-Ring | 1 | 2022 | 68 | 0.050 |
Why?
|
Glioma | 1 | 2017 | 3523 | 0.050 |
Why?
|
Alkenes | 1 | 2001 | 54 | 0.050 |
Why?
|
ROC Curve | 2 | 2022 | 3624 | 0.050 |
Why?
|
Glutamate Carboxypeptidase II | 1 | 2022 | 89 | 0.050 |
Why?
|
Pilot Projects | 2 | 2021 | 8730 | 0.050 |
Why?
|
Palliative Care | 1 | 2017 | 3644 | 0.050 |
Why?
|
Superoxide Dismutase | 1 | 2024 | 596 | 0.050 |
Why?
|
Blood Proteins | 1 | 2007 | 1183 | 0.050 |
Why?
|
Government | 1 | 2022 | 162 | 0.050 |
Why?
|
Temperature | 1 | 2008 | 2237 | 0.050 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2022 | 2048 | 0.050 |
Why?
|
Vaccination | 2 | 2018 | 3434 | 0.050 |
Why?
|
Agriculture | 1 | 2002 | 188 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2020 | 6978 | 0.040 |
Why?
|
Microspheres | 1 | 2024 | 789 | 0.040 |
Why?
|
Practice Guidelines as Topic | 2 | 2015 | 7451 | 0.040 |
Why?
|
Knee | 1 | 2002 | 279 | 0.040 |
Why?
|
DNA Methylation | 1 | 2015 | 4421 | 0.040 |
Why?
|
Autopsy | 1 | 2004 | 1013 | 0.040 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2007 | 1518 | 0.040 |
Why?
|
Blood Chemical Analysis | 1 | 2002 | 436 | 0.040 |
Why?
|
Boston | 3 | 2008 | 9361 | 0.040 |
Why?
|
Pregnancy | 2 | 2015 | 30179 | 0.040 |
Why?
|
Substance-Related Disorders | 1 | 2017 | 4453 | 0.040 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2007 | 1724 | 0.040 |
Why?
|
Eating | 1 | 2007 | 1538 | 0.040 |
Why?
|
Decision Support Systems, Clinical | 2 | 2007 | 1176 | 0.040 |
Why?
|
Rats, Wistar | 1 | 2024 | 1891 | 0.040 |
Why?
|
Aerosols | 1 | 2022 | 637 | 0.040 |
Why?
|
Tissue Distribution | 1 | 2024 | 2298 | 0.040 |
Why?
|
Blood | 1 | 2002 | 597 | 0.040 |
Why?
|
Urban Population | 1 | 2007 | 2047 | 0.040 |
Why?
|
Hospital Communication Systems | 1 | 1999 | 48 | 0.040 |
Why?
|
Leukemia | 1 | 2008 | 1527 | 0.040 |
Why?
|
Pseudohypoparathyroidism | 1 | 2000 | 87 | 0.040 |
Why?
|
Trees | 1 | 1999 | 57 | 0.040 |
Why?
|
Multiple Myeloma | 1 | 2017 | 5192 | 0.040 |
Why?
|
Quarantine | 1 | 2021 | 187 | 0.040 |
Why?
|
Anal Canal | 1 | 2021 | 376 | 0.040 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 1999 | 100 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2017 | 22293 | 0.040 |
Why?
|
Asthma | 1 | 2018 | 6274 | 0.040 |
Why?
|
Skull Base | 1 | 2021 | 294 | 0.040 |
Why?
|
Bilirubin | 1 | 2020 | 439 | 0.040 |
Why?
|
Apoptosis | 1 | 2015 | 9526 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2017 | 9425 | 0.040 |
Why?
|
Portal Pressure | 1 | 2018 | 61 | 0.040 |
Why?
|
Computers | 1 | 2001 | 592 | 0.040 |
Why?
|
Pancreatic Neoplasms | 1 | 2016 | 5442 | 0.040 |
Why?
|
Carbon Dioxide | 1 | 2022 | 1152 | 0.040 |
Why?
|
Contrast Media | 1 | 2011 | 5336 | 0.040 |
Why?
|
Emergencies | 1 | 2024 | 1222 | 0.040 |
Why?
|
Inguinal Canal | 1 | 2017 | 71 | 0.040 |
Why?
|
Neoplasm Invasiveness | 2 | 2017 | 3637 | 0.040 |
Why?
|
Fungemia | 1 | 1997 | 57 | 0.040 |
Why?
|
Therapy, Computer-Assisted | 1 | 1999 | 265 | 0.040 |
Why?
|
Exanthema | 1 | 2002 | 504 | 0.040 |
Why?
|
Injections, Intramuscular | 1 | 2019 | 557 | 0.040 |
Why?
|
Aeromonas | 1 | 2017 | 17 | 0.040 |
Why?
|
Pharmacoepidemiology | 1 | 2001 | 352 | 0.040 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2007 | 1398 | 0.040 |
Why?
|
Data Display | 1 | 1997 | 174 | 0.040 |
Why?
|
Germany | 1 | 2019 | 882 | 0.030 |
Why?
|
Heat-Shock Response | 1 | 2018 | 179 | 0.030 |
Why?
|
Varicose Veins | 1 | 2018 | 157 | 0.030 |
Why?
|
Fatigue | 1 | 2004 | 1556 | 0.030 |
Why?
|
Rural Population | 1 | 2007 | 2317 | 0.030 |
Why?
|
Medical Audit | 1 | 1998 | 454 | 0.030 |
Why?
|
Perineum | 1 | 2017 | 210 | 0.030 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2007 | 2145 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 2018 | 1379 | 0.030 |
Why?
|
Water | 1 | 2022 | 1421 | 0.030 |
Why?
|
Evidence-Based Practice | 1 | 2020 | 500 | 0.030 |
Why?
|
Medicare Part B | 1 | 2017 | 117 | 0.030 |
Why?
|
Kidney | 2 | 2024 | 7064 | 0.030 |
Why?
|
Catheters | 1 | 2019 | 427 | 0.030 |
Why?
|
Consensus | 1 | 2006 | 3207 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2021 | 36840 | 0.030 |
Why?
|
Postoperative Period | 1 | 2020 | 1833 | 0.030 |
Why?
|
Oxygen | 1 | 2007 | 4269 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2017 | 9182 | 0.030 |
Why?
|
Laparotomy | 1 | 2017 | 459 | 0.030 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2007 | 2768 | 0.030 |
Why?
|
Africa South of the Sahara | 1 | 2018 | 750 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2001 | 2863 | 0.030 |
Why?
|
Aftercare | 1 | 2021 | 921 | 0.030 |
Why?
|
Tumor Burden | 1 | 2021 | 1909 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2021 | 2925 | 0.030 |
Why?
|
Risk Management | 1 | 1998 | 558 | 0.030 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2021 | 811 | 0.030 |
Why?
|
Chromosome Breakage | 1 | 2015 | 159 | 0.030 |
Why?
|
Enzyme Induction | 1 | 2015 | 455 | 0.030 |
Why?
|
Dyspnea | 1 | 2002 | 1352 | 0.030 |
Why?
|
Diet | 2 | 2017 | 8098 | 0.030 |
Why?
|
Hospitals, University | 1 | 1995 | 569 | 0.030 |
Why?
|
Erectile Dysfunction | 1 | 2017 | 445 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2018 | 2228 | 0.030 |
Why?
|
Biomedical Research | 1 | 2009 | 3463 | 0.030 |
Why?
|
Clinical Governance | 1 | 2013 | 7 | 0.030 |
Why?
|
Radiography | 1 | 2004 | 6995 | 0.030 |
Why?
|
Culture | 1 | 2017 | 624 | 0.030 |
Why?
|
Scotland | 1 | 2013 | 143 | 0.030 |
Why?
|
Disease-Free Survival | 1 | 2003 | 6856 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2024 | 3145 | 0.030 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 1997 | 620 | 0.030 |
Why?
|
Rectum | 1 | 2017 | 902 | 0.030 |
Why?
|
Comorbidity | 1 | 2007 | 10601 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2015 | 720 | 0.020 |
Why?
|
Tumor Cells, Cultured | 2 | 2017 | 6135 | 0.020 |
Why?
|
Nerve Block | 1 | 2019 | 711 | 0.020 |
Why?
|
Infant, Premature, Diseases | 1 | 2017 | 712 | 0.020 |
Why?
|
Flavonoids | 1 | 1994 | 447 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2022 | 2834 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2017 | 3103 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4861 | 0.020 |
Why?
|
Influenza Vaccines | 1 | 2018 | 781 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6537 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2017 | 1409 | 0.020 |
Why?
|
Tuberculosis | 1 | 2002 | 2030 | 0.020 |
Why?
|
Health Behavior | 1 | 2020 | 2649 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3619 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2007 | 7471 | 0.020 |
Why?
|
Hypercholesterolemia | 1 | 2015 | 1142 | 0.020 |
Why?
|
Learning | 1 | 2018 | 1762 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2020 | 14766 | 0.020 |
Why?
|
Endoscopy | 1 | 2017 | 1857 | 0.020 |
Why?
|
Rats | 1 | 2024 | 23839 | 0.020 |
Why?
|
Patient Access to Records | 1 | 2008 | 120 | 0.020 |
Why?
|
Down-Regulation | 1 | 2015 | 2944 | 0.020 |
Why?
|
Hospital Bed Capacity, 100 to 299 | 1 | 2007 | 11 | 0.020 |
Why?
|
Hospital Bed Capacity, 500 and over | 2 | 1997 | 113 | 0.020 |
Why?
|
Cell Survival | 1 | 2017 | 5801 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2015 | 2150 | 0.020 |
Why?
|
Cell Cycle | 1 | 2015 | 2942 | 0.020 |
Why?
|
Capital Expenditures | 1 | 2006 | 27 | 0.020 |
Why?
|
SEER Program | 1 | 2011 | 1476 | 0.020 |
Why?
|
Colorado | 1 | 2006 | 166 | 0.020 |
Why?
|
Anticonvulsants | 1 | 1995 | 1923 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2018 | 3063 | 0.020 |
Why?
|
Protein Binding | 1 | 2017 | 9376 | 0.010 |
Why?
|
Recurrence | 1 | 2017 | 8510 | 0.010 |
Why?
|
Phagocytes | 1 | 2006 | 294 | 0.010 |
Why?
|
Budgets | 1 | 2006 | 232 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2003 | 6551 | 0.010 |
Why?
|
Medical Records | 1 | 2008 | 1413 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10784 | 0.010 |
Why?
|
Leukemia P388 | 1 | 2001 | 14 | 0.010 |
Why?
|
Delphi Technique | 1 | 2006 | 879 | 0.010 |
Why?
|
Templates, Genetic | 1 | 2001 | 189 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 9507 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2017 | 8635 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2017 | 6657 | 0.010 |
Why?
|
Drug Utilization | 1 | 2006 | 1192 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2006 | 2733 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 17149 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18388 | 0.010 |
Why?
|
Survivors | 1 | 2008 | 2381 | 0.010 |
Why?
|
Erythrocytes | 1 | 2006 | 2422 | 0.010 |
Why?
|
Enzyme Multiplied Immunoassay Technique | 1 | 1995 | 7 | 0.010 |
Why?
|
Laboratories, Hospital | 1 | 1997 | 192 | 0.010 |
Why?
|
Plant Extracts | 1 | 1999 | 499 | 0.010 |
Why?
|
Hypertension | 1 | 2015 | 8611 | 0.010 |
Why?
|
Phenytoin | 1 | 1995 | 190 | 0.010 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 1997 | 342 | 0.010 |
Why?
|
Phenobarbital | 1 | 1995 | 192 | 0.010 |
Why?
|
Carbamazepine | 1 | 1995 | 224 | 0.010 |
Why?
|
Molecular Structure | 1 | 1999 | 1889 | 0.010 |
Why?
|
Mice | 2 | 2017 | 82045 | 0.010 |
Why?
|
Radiology Department, Hospital | 1 | 1997 | 409 | 0.010 |
Why?
|
Medical Staff, Hospital | 1 | 1997 | 603 | 0.010 |
Why?
|
Valproic Acid | 1 | 1995 | 443 | 0.010 |
Why?
|
Chick Embryo | 1 | 1994 | 978 | 0.010 |
Why?
|
Organ Culture Techniques | 1 | 1994 | 796 | 0.010 |
Why?
|
Models, Molecular | 1 | 2001 | 5443 | 0.010 |
Why?
|
Staphylococcus aureus | 1 | 1997 | 1461 | 0.010 |
Why?
|
Observer Variation | 1 | 1995 | 2622 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 1994 | 3073 | 0.000 |
Why?
|
Staphylococcal Infections | 1 | 1997 | 1412 | 0.000 |
Why?
|
Heart | 1 | 1994 | 4451 | 0.000 |
Why?
|